None listed
Conditions
Interventions
BP-Master early assisted group:BP-Master aid was used in the first stage and no aid was used in the second stage
BP-Master late assisted group:No aids are used in the first stage, and BP-master is used in the second stage
Sponsors
First Affiliated Hospital of Army Medical University
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1. Endoscopist: (1) Proficient in the routine gastroenteroscopy, with the total number of endoscopic diagnosis and treatment more than 10,000 cases, and the working years of endoscopic diagnosis and treatment >=5 years; (2) Familiar with endoscopic ultrasonography, able to independently complete 8-station scanning of biliary and pancreatic endoscopic ultrasonography, and independent endoscopic ultrasonography was performed in >=150 cases. 2. Patient: (1) No gender limit, aged 18 years or above; (2) Be able to read, understand and sign informed consent; (3) Biliary and pancreatic diseases is suspected, and endoscopic ultrasonography is needed to determine the development of the disease; (4) Clinical symptoms and/or radiological and/or laboratory findings suspect the presence of biliary pancreatic disease (5) High-risk patients with pancreatic cancer: gene mutations known to be associated with pancreatic cancer risk (BRCA2, BRCA1, PALB2, ATM, CDKNA/p16); Familial ductal adenocarcinoma of pancreas; Peutz-Jeghers syndrome (STK11); Lynch syndrome (MLH1/MSH2/MSH6, EPCAM, PMS2); Familial adenomatous polyposis (APC), etc.; (6) The investigator believed that the subjects understood the clinical study procedures and were willing and able to complete all study procedures and follow-up visits and cooperate with the study procedures.
Exclusion criteria
Exclusion criteria: 1. Endoscopist: unable to participate in the two stages before and after self-control. 2. Patient: (1) Have participated in other clinical trials, signed informed consent and are in the follow-up period of other clinical trials; (2) Have participated in clinical trials of the drug and are in the washout period of the test drug or the control drug; (3) Absolute contraindications of endoscopic ultrasonography; (4) Drug or alcohol abuse or psychological disorder in the last 5 years; (5) Pregnant or lactating patients; (6) Bleeding risk or thrombocytopenia; (7) Previous history of digestive system surgery; (8) Serious medical diseases; (9) Upper gastrointestinal obstruction; (10) Previous history of allergic reactions to anesthetics; (11) Anatomical abnormalities of the upper digestive tract caused by advanced tumors; (12) The investigator believes that the patient is not suitable for endoscopic ultrasonography; (13) The investigator considers that the patient has a high-risk disease or other special condition that is not suitable for clinical trials.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Missed scanning rate of standard station; | — |
Secondary
| Measure | Time frame |
|---|---|
| Miss rate per standard station;Missed scanning rate of anatomical landmarks;Missed scanning rate of per anatomical landmarks;Operation time; | — |
Countries
China
Contacts
Public ContactChen Lei
First Affiliated Hospital of Army Medical University
Outcome results
None listed